Streptococcus Group B Antikörper (HRP)

Produktnummer ABIN112835

Produktdetails anti-Streptococcus Group B Antikörper (HRP)

Target: Streptococcus Group B

Reaktivität: Streptococcus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Streptococcus Group B Antikörper ist konjugiert mit HRP

Applikation: Enzyme Immunoassay (EIA)

Aufreinigung: Immunoaffinity chromatography.

Immunogen: Streptococci, group B

Anwendungsinformationen

Applikationshinweise: Suitable for use in ELISA.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.0 mg/mL (OD280 nm, E0.1% = 1.4)

Buffer: PBS containing 10 mg/mL BSA as stabilizer and 0.002 % Thimerosal as preservative.

Konservierungsmittel: Thimerosal (Merthiolate)

Vorsichtsmaßnahmen: This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu Streptococcus Group B

Target: Streptococcus Group B

Abstract: Streptococcus Group B Produkte

Substanzklasse: Bacteria

Hintergrund: Streptococci form part of the normal human flora that resides on the skin, and can also colonise the respiratory, gastrointestinal, and genitourinary tracts. Streptococci can cause a range of diseases, from the less serious but common sore throats and skin infections to life threatening conditions such as necrotising fasciitis. Different streptococcal species are involved in human disease, broadly categorised as pus forming or pyogenic streptococci, non pus forming or non pyogenic streptococci, and Streptococcus pneumoniae. Streptococci are classified into Lancefield serotypes by their cell wall polysaccharide antigens. Group A are primarily pathogens. Group B streptococci (including Streptococcus agalactiae) are the leading bacterial causes of human neonatal illness and death causing opportunistic invasive disease in pregnant women such as preterm labour, membrane rupture and urinary tract infections and sepsis and meningitis in newborns.